Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Solon Eiendom ASA : Sales in Q2 2018

Solon Eiendom ASA
Posted on: 02 Jul 18

Oslo, July 2, 2018 - Solon Eiendom sold 107 homes with a total sales value of NOK 733 million during the second quarter of 2018 compared to 68 homes with a total sales value of NOK 685 million in the second quarter of 2017. YTD 2018 Solon Eiendom has sold 232 homes with a total sales value of NOK 1 559 million compared to 126 homes with a total sales value of NOK 1 092 million in the same period last year.
  
In Q2 2018, 4 homes were completed and 6 delivered, compared to 4 completed, and 6 delivered in Q2 2017. At quarter end, 96% of the remaining 55 planned completions in 2018 have been sold.

Adjusted for Solon Eiendom's ownership, sales in Q2 2018 amounted to 94 homes worth NOK 652 million compared to 65 homes with a total sales value of NOK 610 million in the second quarter of 2017.

The company had 218 homes under construction of which 89 % have been sold at June 30, 2018.

For further information, please contact:
Andreas Martinussen, Chief Executive Officer, Solon Eiendom ASA
Tel:     +47 400 00 405, email:    am@soloneiendom.no

Scott Danielsen, Chief Financial Officer, Solon Eiendom ASA
Tel:     +47 952 55 620, email:  sd@soloneiendom.no

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. SEA20180702_SOLON_Sales_Q2_2018


This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Solon Eiendom ASA via GlobeNewswire
HUG#2202431
GlobeNewswire
globenewswire.com

Last updated on: 03/07/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.